158 related articles for article (PubMed ID: 37735371)
1. Incident Kaposi sarcoma during the expansion of antiretroviral therapy eligibility in Nigeria: a retrospective cohort study.
Akanbi MO; Bilaver LA; Achenbach C; Hirschhorn LR; Rivera AS; Adekolujo OS; Adekola KUA; Silas OA; Agaba PA; Agbaji O; Shehu NY; Sagay SA; Hou L; Murphy RL
BMC Cancer; 2023 Sep; 23(1):890. PubMed ID: 37735371
[TBL] [Abstract][Full Text] [Related]
2. Analyses of Kaposi Sarcoma trends among adults establishing initial outpatient HIV care in Nigeria: 2006-2017.
Akanbi MO; Bilaver LA; Achenbach C; Hirschhorn LR; Rivera AS; Silas OA; Agaba PA; Agbaji O; Shehu NY; Sagay SA; Hou L; Murphy RL
Infect Agent Cancer; 2022 Mar; 17(1):10. PubMed ID: 35313941
[TBL] [Abstract][Full Text] [Related]
3. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.
Letang E; Lewis JJ; Bower M; Mosam A; Borok M; Campbell TB; Naniche D; Newsom-Davis T; Shaik F; Fiorillo S; Miro JM; Schellenberg D; Easterbrook PJ
AIDS; 2013 Jun; 27(10):1603-13. PubMed ID: 23462220
[TBL] [Abstract][Full Text] [Related]
4. Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort study.
Rohner E; Valeri F; Maskew M; Prozesky H; Rabie H; Garone D; Dickinson D; Chimbetete C; Lumano-Mulenga P; Sikazwe I; Wyss N; Clough-Gorr KM; Egger M; Chi BH; Bohlius J
J Acquir Immune Defic Syndr; 2014 Dec; 67(5):547-54. PubMed ID: 25393941
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.
Bohlius J; Valeri F; Maskew M; Prozesky H; Garone D; Sengayi M; Fox MP; Davies MA; Egger M
Int J Cancer; 2014 Dec; 135(11):2644-52. PubMed ID: 24729433
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study.
AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord
Clin Infect Dis; 2017 Oct; 65(8):1316-1326. PubMed ID: 28531260
[TBL] [Abstract][Full Text] [Related]
7. Changing Incidence and Risk Factors for Kaposi Sarcoma by Time Since Starting Antiretroviral Therapy: Collaborative Analysis of 21 European Cohort Studies.
Cancer Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord
Clin Infect Dis; 2016 Nov; 63(10):1373-1379. PubMed ID: 27535953
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral therapy and Kaposi's sarcoma trends and outcomes among adults with HIV in Latin America.
Castilho JL; Kim A; Jenkins CA; Grinsztejn B; Gotuzzo E; Fink V; Padgett D; Belaunzaran-Zamudio PF; Crabtree-Ramírez B; Escuder MM; Souza RA; Tenore SB; Pimentel SR; Ikeda MLR; de Alencastro PR; Tupinanbas U; Brites C; Luz E; Netto J; Cortes CP; Grangeiro A; Shepherd BE; McGowan CC;
J Int AIDS Soc; 2021 Jan; 24(1):e25658. PubMed ID: 33405281
[TBL] [Abstract][Full Text] [Related]
9. Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study.
Maskew M; Fox MP; van Cutsem G; Chu K; Macphail P; Boulle A; Egger M; Africa FI
PLoS One; 2013; 8(6):e64392. PubMed ID: 23755122
[TBL] [Abstract][Full Text] [Related]
10. Kaposi sarcoma-associated herpesvirus, HIV-1 and Kaposi sarcoma risk in black South Africans diagnosed with cancer during antiretroviral treatment rollout.
Motlhale M; Muchengeti M; Bradshaw D; Chen WC; Singini MG; de Villiers CB; Lewis CM; Bender N; Mathew CG; Newton R; Waterboer T; Singh E; Sitas F
Int J Cancer; 2023 May; 152(10):2081-2089. PubMed ID: 36727526
[TBL] [Abstract][Full Text] [Related]
11. A prospective ascertainment of cancer incidence in sub-Saharan Africa: The case of Kaposi sarcoma.
Semeere A; Wenger M; Busakhala N; Buziba N; Bwana M; Muyindike W; Amerson E; Maurer T; McCalmont T; LeBoit P; Musick B; Yiannoutsos C; Lukande R; Castelnuovo B; Laker-Oketta M; Kambugu A; Glidden D; Wools-Kaloustian K; Martin J
Cancer Med; 2016 May; 5(5):914-28. PubMed ID: 26823008
[TBL] [Abstract][Full Text] [Related]
12. Impact of Protease Inhibitors on HIV-Associated Kaposi Sarcoma Incidence: A Systematic Review.
Chang E; Mapakshi SR; Mbang P; El-Mallawany NK; Kramer JR; White DL; Chiao EY
J Acquir Immune Defic Syndr; 2018 Oct; 79(2):141-148. PubMed ID: 29985803
[TBL] [Abstract][Full Text] [Related]
13. Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.
; Rohner E; Schmidlin K; Zwahlen M; Chakraborty R; Clifford G; Obel N; Grabar S; Verbon A; Noguera-Julian A; Collins IJ; Rojo P; Brockmeyer N; Campbell M; Chêne G; Prozesky H; Eley B; Stefan DC; Davidson A; Chimbetete C; Sawry S; Davies MA; Kariminia A; Vibol U; Sohn A; Egger M; Bohlius J
Clin Infect Dis; 2016 Nov; 63(9):1245-1253. PubMed ID: 27578823
[TBL] [Abstract][Full Text] [Related]
14. Kaposi sarcoma in people living with HIV: incidence and associated factors in a French cohort between 2010 and 2015.
Poizot-Martin I; Lions C; Cheret A; Rey D; Duvivier C; Jacomet C; Allavena C; Huleux T; Bani-Sadr F; Obry-Roguet V; Makinson A;
AIDS; 2020 Mar; 34(4):569-577. PubMed ID: 31764070
[TBL] [Abstract][Full Text] [Related]
15. High Cancer Burden Among Antiretroviral Therapy Users in Malawi: A Record Linkage Study of Observational Human Immunodeficiency Virus Cohorts and Cancer Registry Data.
Horner MJ; Chasimpha S; Spoerri A; Edwards J; Bohlius J; Tweya H; Tembo P; Nkhambule F; Phiri EM; Miller WC; Malisita K; Phiri S; Dzamalala C; Olshan AF; Gopal S
Clin Infect Dis; 2019 Aug; 69(5):829-835. PubMed ID: 30452634
[TBL] [Abstract][Full Text] [Related]
16. The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study.
Mocroft A; Kirk O; Clumeck N; Gargalianos-Kakolyris P; Trocha H; Chentsova N; Antunes F; Stellbrink HJ; Phillips AN; Lundgren JD
Cancer; 2004 Jun; 100(12):2644-54. PubMed ID: 15197808
[TBL] [Abstract][Full Text] [Related]
17. Treatment and outcome of AIDS-related Kaposi sarcoma in South Africa, Malawi and Zambia: an international comparison.
Rohner E; Kasaro M; Msadabwe-Chikuni SC; Stinson K; Mohamed Z; Tweya H; Egger M; Bohlius J
Pan Afr Med J; 2017; 28():261. PubMed ID: 29881504
[TBL] [Abstract][Full Text] [Related]
18. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy.
Mukhtar F; Ilozumba M; Utuama O; Cimenler O
JAMA Oncol; 2018 Jan; 4(1):48-53. PubMed ID: 28837714
[TBL] [Abstract][Full Text] [Related]
19. Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.
Dubrow R; Qin L; Lin H; Hernández-Ramírez RU; Neugebauer RS; Leyden W; Althoff KN; Achenbach CJ; Hessol NA; Modur SP; DʼSouza G; Bosch RJ; Grover S; Horberg MA; Kitahata MM; Mayor AM; Novak RM; Rabkin CS; Sterling TR; Goedert JJ; Justice AC; Engels EA; Moore RD; Silverberg MJ;
J Acquir Immune Defic Syndr; 2017 Aug; 75(4):382-390. PubMed ID: 28394855
[TBL] [Abstract][Full Text] [Related]
20. Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States.
Yanik EL; Achenbach CJ; Gopal S; Coghill AE; Cole SR; Eron JJ; Moore RD; Mathews WC; Drozd DR; Hamdan A; Ballestas ME; Engels EA
J Clin Oncol; 2016 Sep; 34(27):3276-83. PubMed ID: 27507879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]